Bausch Health Co. Inc. (BHC) Tops Q2 EPS by 12c; Offers Guidance

Bausch Health Co. Inc. (NYSE: BHC) reported Q2 EPS of $0.07, $0.12 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $2.17 billion versus the consensus estimate of $2.04 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2023 revenue of $8.45-8.65 billion, versus the consensus of $8.35 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
• NVE Corporation names new CEO and expands board to seven members